Accelerating cervical cancer control and prevention
Menée à l'aide d'une modélisation, cette étude estime l'effet de quatre scénarios d'implantation de programmes de vaccination contre le papillomavirus humain et de programmes de dépistage du cancer du col utérin sur l'évolution de l'incidence de cette maladie en Angleterre jusqu'en 2040
Cervical cancer is probably the best understood and most preventable of all major human malignancies. The progressive steps of this disease—human papillomavirus (HPV) infection, progression to precancer, and invasion—are well described (figure).1 Sexual transmission of causal HPV infections is ubiquitous but the rates of cervical cancer vary widely, inversely related to the effectiveness of prevention programmes. Almost 90% of deaths occur in low-income and middle-income countries. In high-income countries, cervical cancer has been relatively well controlled by expensive but effective prevention programmes based on cervical cytology screening.